Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812552 · ClinicalTrials.gov registry record
Drug Eluting Stent Registry of Thrombosis
A clinical trial of Coronary Artery Disease, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- 984
- Enrollment target
- 20
- Study locations
NCT00812552 is a study of Coronary Artery Disease that has completed, run by Medstar Health Research Institute. The registered enrollment target is 984 participants, below the 1,282-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (23% lower). The trial reports 20 study locations across 18 states.
The verdict
NCT00812552, a study of Coronary Artery Disease, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- 984 participants
- Enrollment target
- 20
- Study locations
Study Summary
Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.
Conditions Studied
Study Locations (20)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- Lahey Clinic - Burlington
New York
- New York Methodist Hospital - Brooklyn
- Columbia University Medical Center - New York
California
- Mercy General Hospital / Mercy Heart and Vascular Institute Cardiovascular Research - Sacramento
District of Columbia
- Washington Hospital Center - Washington D.C.
Illinois
- Prairie Education and Research Cooperative - Springfield
Kentucky
- Lexington Cardiac Research Foundation/Central Baptist Hospital - Lexington
Maine
- Maine Medical Center - Portland
Maryland
- Washington Adventist Hospital - Takoma Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 984 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00812552
The ClinicalTrials.gov registry entry for NCT00812552 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 984 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,282-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (23% lower). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00812552 reports 20 study locations spanning 18 distinct geographic areas - top geographies include Massachusetts, New York, California.
Frequently Asked Questions
What is clinical trial NCT00812552 about?
NCT00812552 is a clinical study titled "Drug Eluting Stent Registry of Thrombosis". Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.
What is the current status of trial NCT00812552?
This trial is currently completed. The enrollment target is 984 participants. The study started on 2009-09. Estimated completion is 2012-05.
What conditions does trial NCT00812552 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
Who is sponsoring clinical trial NCT00812552?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00812552 being conducted?
This trial has 20 study locations across California, District of Columbia, Illinois, Kentucky, Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.